Devansu Tewari

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

Devansu Tewari, James Java, Ritu Salani et al. · Journal of Clinical Oncology · 2015 · 286 citations · Full text

Medicine, Gynecology, Oncology +12

Conserved Methylation Patterns of Human Papillomavirus Type 16 DNA in Asymptomatic Infection and Cervical Neoplasia

Mina Kalantari, Itzel E. Calleja‐Macías, Devansu Tewari et al. · Journal of Virology · 2004 · 180 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21–65 Years in a Large Integrated Health Care System — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020

Maureen J. Miller, Lanfang Xu, Jin Qin et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 167 citations · Full text

Medicine, Health Policy, Preventive Medicine +17

Cloning of a Surface Membrane Glycoprotein Specific for the Infective Form of Trypanosoma cruzi Having Adhesive Properties to Laminin

Ricardo J. Giordano, David L. Fouts, Devansu Tewari et al. · Journal of Biological Chemistry · 1999 · 115 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial

Rodney P. Rocconi, Elizabeth A. Grosen, Sharad Ghamande et al. · The Lancet Oncology · 2020 · 115 citations

Medicine, Immunology, Oncology +12